On the 24th of August 2001, a group of business and licensing executives united in Basel and founded the Swiss Pharma Licensing Group. The first Board defined objectives, recruited members and set up the foundation for today’s association.
With the current situation of Corona virus pandemic, the Swiss HLG board decided to cancel the Summer Conference 2020, which was scheduled to take place on 18th June 2020. The board is working on an alternative date which shall be communicated in due time.
Swiss HLG has contemplated a conversion of the event to a remote or virtual conference, as did some of the BD&L conferences, however Networking being one of our cornerstones, we preferred to postpone to a better time when we will be able to maintain our traditional conferences with the one-on-one interactions.
We are confident that you would understand and we thank you for your support.
We wish you and your family healthy weeks ahead.
The Swiss HLG, a non-profit association of Business Development and Licensing professionals, held its 31st Conference titled “DEAL-MAKING IN THE ROUGH”, in a beautiful setting in the Swiss Alps. The topic of discussion focused on the fact we are living in provoking times: The pharmaceutical and biotech industry as a whole and the professional business developers, alliance managers and dealmakers have to cope with a disruptive and changing environment in which deal making will become more and more complex and ambitious.
Over two and a half days, more than 85 delegates from Switzerland, Europe, the US and Asia gathered in the Swiss Alps to explore and discuss new trends in partnering and deal-making in the current tumult of our industry with the overall objective to capture the maximum value with professional capabilities and high-calibre talents.
Swiss HLG members €100 DISCOUNT and Start-up Members €150 DISCOUNT off the early bird rate *limited offer so hurry and register now!
